Wells Fargo
IDNA icon

Wells Fargo’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Wells Fargo’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Buy
95,351
+70,492
+284% +$2.11M ﹤0.01% 3220
2026
Q1 		$722K Buy
24,859
+1,313
+6% +$38.1K ﹤0.01% 3942
2025
Q4 		$617K Buy
23,546
+6,974
+42% +$179K ﹤0.01% 4328
2025
Q3 		$391K Buy
16,572
+1,638
+11% +$36.2K ﹤0.01% 4473
2025
Q2 		$306K Buy
14,934
+899
+6% +$18.1K ﹤0.01% 4487
2025
Q1 		$288K Buy
14,035
+1,086
+8% +$24.2K ﹤0.01% 4455
2024
Q4 		$293K Buy
12,949
+11,027
+574% +$265K ﹤0.01% 4547
2024
Q3 		$47.3K Buy
1,922
+426
+28% +$10.4K ﹤0.01% 5362
2024
Q2 		$34.6K Sell
1,496
-455
-23% -$10.7K ﹤0.01% 5423
2024
Q1 		$47K Sell
1,951
-1,908
-49% -$44.7K ﹤0.01% 5279
2023
Q4 		$88.8K Sell
3,859
-1,080
-22% -$21.7K ﹤0.01% 4977
2023
Q3 		$101K Sell
4,939
-5,809
-54% -$130K ﹤0.01% 4775
2023
Q2 		$251K Buy
10,748
+457
+4% +$11K ﹤0.01% 4444
2023
Q1 		$239K Buy
10,291
+3,272
+47% +$81.9K ﹤0.01% 4322
2022
Q4 		$177K Buy
7,019
+670
+11% +$18K ﹤0.01% 4239
2022
Q3 		$168K Sell
6,349
-447
-7% -$13.8K ﹤0.01% 4336
2022
Q2 		$196K Sell
6,796
-1,900
-22% -$56.7K ﹤0.01% 4292
2022
Q1 		$300K Sell
8,696
-14,029
-62% -$496K ﹤0.01% 4748
2021
Q4 		$996K Buy
+22,725
New +$1.08M ﹤0.01% 4110

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo's IDNA Position: Q2 2026 in Review

Wells Fargo increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 284% in Q2 2026, buying an estimated $2.11M and bringing the position to 95,351 shares worth $3.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3220.

Wells Fargo first reported a position in IDNA in Q4 2021 and has held it in 19 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Wells Fargo held 95,351 shares of iShares Genomics Immunology and Healthcare ETF worth $3.22M as of Q2 2026.
  • Wells Fargo bought 70,492 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $2.11M.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3220 holding.
  • Wells Fargo first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and has held it in 19 quarters since.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.